Skip to content

AdaptHealth AHCO Debt Issuance Proceeds

Debt Issuance Proceeds at other companies

GHC
Graham HoldingsGHC
$134.72M+9,599%
Tandem Diabetes Care logo
Tandem Diabetes CareTNDM
$291.16M
Amylyx Pharmaceuticals, Inc. logo
Amylyx Pharmaceuticals, Inc.AMLX
$191.11M
GE HealthCare Technologies logo
GE HealthCare TechnologiesGEHC
$1.15B
Savara logo
SavaraSVRA
$29.6M

Other financials

Income statement

See full
Revenue$819.8M+5.4%
Gross profit$111.5M-7.4%
Operating income$5.5M-76.3%
Net income-$16.0M-123%
EPS (diluted)-$0.12-140%

Balance sheet

See full
Cash & equivalents$48.0M-10.6%
Total debt$2.0B-4.9%
Total equity$1.5B-3.9%
Total assets$4.4B-0.3%

Cash flow

See full
Operating cash flow$93.7M-1.9%
CapEx$121.2M+26.8%
Free cash flow-$27.5M-47,297%

Valuation

See full
Market cap$1.36B+20.5%
Enterprise value$3.32B+4.3%
P/S0.4×+0.1×

Profitability

See full
Gross margin18.3%-1.6pp
Operating margin8%+6.9pp
Net margin-2.4%-5.1pp
FCF margin5.8%-2.6pp

Returns & leverage

See full
Return on equity-5.2%-10.8pp
Debt / equity1.3×0.0×
Current ratio0.9×-0.4×

Where this comes from

Reported directly by AdaptHealth in its filing.

Tagged under the XBRL concept us-gaap:ProceedsFromLinesOfCredit.

The official record: AdaptHealth’s 10-Q, filed May 5, 2026, on SEC EDGAR. View the filing →

Ask your AI about AdaptHealth's debt issuance proceeds.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is AdaptHealth's debt issuance proceeds?
AdaptHealth (AHCO) reported debt issuance proceeds of $100M in Q1 2026.
What is the long-term trend for AdaptHealth's debt issuance proceeds?
Over 2 years (2021 to 2025), AdaptHealth's debt issuance proceeds has grown at a -100.0% compound annual growth rate (CAGR), from $1.17B to $0.
What does debt issuance proceeds mean?
Cash received from issuing bonds, notes, term loans, and other debt instruments in the capital markets or from bank lending.